Profile
SEEL VRTX ALNY REGN ARGX SGEN
Company Name Seelos Therapeutics, Inc. Vertex Pharmaceuticals Incorporated Alnylam Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. argenx SE Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $214.97K $101.65B $61.42B $57.97B $46.27B $43.15B
Employees 0.01K 6.10K 2.23K 15.16K 1.60K 3.26K
CEO Raj Mehra Reshma Kewalramani FASN, Yvonne L. Greenstreet Leonard S. Schleifer Timothy Van Hauwermeiren EMBA, David R. Epstein
Ratings
SEEL VRTX ALNY REGN ARGX SGEN
Quant Rating Score 2 4 1 4 4 3
Quant Rating Sell Buy Strong Sell Buy Buy Neutral
Trading
SEEL VRTX ALNY REGN ARGX SGEN
Last Close $0.37 $391.36 $461.24 $575.06 $752.32 $228.74
High 52 $3.9 $516.74 $482.13 $1150.19 $768 $228.74
Low 52 $0.19 $366.54 $224.58 $482.92 $519.76 $228.74
Price vs. 52 Week High -90.51 % -24.26 % -4.33 % -50 % -2.04 % 0 %
Price vs. 52 Week Low 94.74 % 6.77 % 105.38 % 19.08 % 44.74 % 0 %
Total Return
SEEL VRTX ALNY REGN ARGX SGEN
1 Month Return 0 % -0.36 % 2.75 % -0.92 % 15.06 % 0 %
3 Month Return 0 % -11.46 % 49.37 % 12.99 % 39.14 % 0 %
6 Month Return 0 % -23.82 % 82.16 % -15.15 % 22.49 % 0 %
9 Month Return 0 % -16.6 % 87.05 % -22.29 % 17.86 % 0 %
YTD Return 0 % -2.82 % 96.01 % -19.27 % 22.33 % 0 %
1 Year Return 64.44 % -18.68 % 68.05 % -49.85 % 44.06 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
SEEL VRTX ALNY REGN ARGX SGEN
Dividend Yield Percentage (TTM) - - - 0.47 % - -
Dividend Paid and Capex Coverage Ration (TTM) - 11.09 % -0.43 % 4.37 % -44.32 % -5.87 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 4.18 % - -
Growth
SEEL VRTX ALNY REGN ARGX SGEN
Asset Growth -76.18 % -0.87 %
Gross Profit Growth -52567.92 % 10.25 %
Revenue Growth - 11.66 %
Revenue 3 Year - 45.6 %
Revenue 5 Year - 163.93 %
Revenue 10 Year -97.95 % 1632.15 %
EBIT Growth 48.58 % -93.69 %
Net Income Growth 50.25 % -114.8 %
Net Income 3 Yeari Growth Per Share 39.98 % -122.89 %
Net Income 5 Yeari Growth Per Share 81.97 % -145.38 %
Net Income 10 Yeari Growth Per Share 94.76 % 33.84 %
Operating Income Growth 42.89 % -106.08 %
Operating Cash Flow Growth (CFG) 61.18 % -113.93 %
Operating 3 Year CFG 65.18 % -118.65 %
Operating 5 Year CFG 87.06 % -131.3 %
Operating 10 Year CFG 96.28 % 12.43 %
EPS Growth 64.01 % -114.8 %
EPS Diluted Growth 64.01 % -114.97 %
Book Value Per Share -128.45 % -6.59 %
Share Holder 3 Year Equity Growth Per Share -496.75 % 62.6 %
Share Holder 5 Year Equity Growth Per Share -157.3 % 168.85 %
Share Holder 10 Year Equity Growth Per Share -107.15 % 1292.6 %
Dividend Per Share Growth - -
Dividend 3 Year Growth Per Share - -
Dividend 5 Year Growth Per Share - -
Dividend 10 Year Growth Per Share - -
Debt Growth -29.29 % 116.42 %
Free Cash Flow Growth 61.18 % -124.1 %
Updated On 31 Dec 2023 31 Dec 2024
Profitability
SEEL VRTX ALNY REGN ARGX SGEN
Gross Profit Margin TTM 19.37 % 86.11 % 83.64 % 81.98 % 65.32 % 79.1 %
Return on Assets TTM -40.07 % 15.13 % -6.99 % 11.67 % 15.06 % -16.61 %
Return on Equity TTM 3.12 % 22.14 % -274.21 % 15.11 % 18.96 % -20.8 %
Return on Capital Employed TTM 32.68 % 19.72 % -5.52 % 11.45 % 5.04 % -21.46 %
Net Income Per EBT TTM 100 % 83.16 % 84.06 % 91.46 % 237.3 % 101.33 %
EBT Per Ebit TTM 10.38 % 111.48 % 210.66 % 123.23 % 147.38 % 98.26 %
EBIT Per Revenue TTM -962.72 % 34.36 % -7.32 % 27.83 % 13.47 % -31.24 %
Cash Flow To Debt Ratio TTM -55.27 % 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Receivables Turnover TTM 5.08 6.03 4.34 2.53 1.91 3.91
Payables Turnover TTM 0.05 0.43 3.93 3.54 0.88 1.97
Inventory Turnover TTM - 1.06 5.62 0.8 2.21 0.96
Fixed Asset Turnover TTM 2031.91 % 431.08 % 355.68 % 293.64 % 5009.77 % 665.41 %
Asset Turnover TTM 40.11 % 47.51 % 53.92 % 37.19 % 31.97 % 53.41 %
Operating Cash Flow Per Share TTM -6.49 14.98 -0.12 45.13 -1.07 -2.46
Free Cash Flow Per Share TTM -6.49 13.63 -0.4 36.58 -1.09 -2.88
Cash Per Share TTM 34.01 % 3036 % 2203.63 % 7107.14 % 5536.58 % 939.52 %
Operating Cash Flow Sales Ratio TTM -587.85 % 33.68 % -0.63 % 33.37 % -3.31 % -23.12 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 90.99 % 335.21 % 81.05 % 102.26 % 117.04 %
Cash Flow Coverage Ratios TTM -55.27 % 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Price To Free Cash Flows Ratio TTM -0.04 29.05 -1179.18 15.08 -596.18 -81.26
Price To Operating Cash Flows Ratio TTM -0.06 26.46 -3910.39 12.33 -706.75 -93.1
Price Cash Flow Ratio TTM -0.06 26.46 -3910.39 12.33 -706.75 -93.1
Income Statement (TTM)
SEEL VRTX ALNY REGN ARGX SGEN
Revenue $0B $11.02B $2.25B $14.2B $2.19B $1.96B
Gross Profit $-0.03B $9.49B $1.92B $11.75B $1.96B $1.55B
Gross Profit Ratio -1267.09% 86.11% 85.62% 82.74% 89.62% 79.1%
EBITDA $-0.04B $0.49B $-0.18B $5.32B $0.11B $-0.62B
Net Income $-0.04B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
EPS Diluted -7.73 -2.08 -2.16 38.34 12.78 -3.3
Balance Sheet (MRQ)
SEEL VRTX ALNY REGN ARGX SGEN
Long Term Debt $0B $1.66B $1.25B $2.7B $0.03B $0.04B
Total Liabilities $0.04B $6.12B $4.17B $8.41B $0.7B $0.87B
Total Equity $-0.03B $16.41B $0.07B $29.35B $5.5B $2.8B
Total Investments $0B $6.65B $1.73B $15.42B $1.93B $1.42B
Total Debt $0.01B $1.75B $1.3B $2.7B $0.04B $0.04B
Total Assets $0.01B $22.53B $4.24B $37.76B $6.2B $3.67B
Cash Flow Statement (TTM)
SEEL VRTX ALNY REGN ARGX SGEN
Net Income $-0.04B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
Inventory $0B $-0.52B $0.01B $-0.62B $-0.1B $-0.23B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.02B $-0.49B $-0.01B $4.42B $-0.08B $-0.45B
Capital Expenditure $0B $-0.3B $-0.03B $-0.76B $-0.07B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 39.2
AARD Aardvark Therapeutics, Inc. Common Stock 10.99
ABCL AbCellera Biologics Inc. 4.565
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.635
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.255
ABPWW 0.046281
ABSI Absci Corporation 2.555
ABUS Arbutus Biopharma Corporation 4.425
ABVC ABVC BioPharma, Inc. 2.8645
ABVX Abivax SA American Depositary Shares 81.05
ACAD ACADIA Pharmaceuticals Inc. 24.2
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.7602
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.965
ACIU AC Immune SA 2.46
ETFs With Exposure to SEEL
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 325.11
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 143.9
VXF Vanguard Extended Market Index Fund 0 209.23
XAW.TO iShares Core MSCI All Country World ex Canada Index ETF 0 49.64
XUU.TO iShares Core S&P U.S. Total Market Index ETF 0 66.91
XUH.TO iShares Core S&P U.S. Total Market Index ETF (CAD-Hedged) 0 53.5
XTR.TO iShares Diversified Monthly Income ETF 0 11.63
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 110.68
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 110.67
XBAL.TO iShares Core Balanced ETF Portfolio 0 32.73
XCNS.TO iShares Core Conservative Balanced ETF Portfolio 0 25.11
XEQT.TO iShares Core Equity ETF Portfolio 0 38.26
XGRO.TO iShares Core Growth ETF Portfolio 0 33.85
XINC.TO iShares Core Income Balanced ETF Portfolio 0 21.28
VTSAX Vanguard Total Stock Market Index Fund 0 158.41
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 158.72
VITSX Vanguard Total Stock Market Index Fund 0 158.44
IBRN iShares Neuroscience and Healthcare ETF 0.0146 25.5232
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000308553 16
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 158.73
JKK iShares Morningstar Small-Cap Growth ETF 0.01 307.42
JKJ iShares Morningstar Small-Cap ETF 0.01 231.193
PSIL AdvisorShares Psychedelics ETF 0.16 16.9201
JKL iShares Morningstar Small-Cap Value ETF 0.01 172.726
VEMPX Vanguard Extended Market Index InstlPlus 0 391.7
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 297.22
Unlock